Some patients treated with 5-fluorouracil (5-FU) metabolize the drug slowly and are at risk for excessive toxicity. Bocci et al used a trial dose of 5-FU to determine kinetic parameters in a patient prior to starting a regular course of therapy. The authors are from the University of Pisa, General Hospital Lucca and General Hospital Livorno in Italy.